FAQ

Oncogene YES-1

Known as: YES1, YES1 Gene 
The gene product of oncogene YES-1 is associated with tyrosine kinase activity and its amino acid sequence shows high similarity with that of SRC… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1993-2017
012319932017

Related topics

Related topics

6 relations
18p11.31-p11.21Homo sapiensNeoplastic Cell TransformationProtein phosphorylation
(More)

Related mentions per year

Related mentions per year

1937-2018
19401960198020002020
Oncogene YES-1
Signal Transduction
Homo sapiens
Neoplastic Cell Transformation
Protein phosphorylation
YES1 gene

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Long noncoding RNA H19 competitively binds miR-17-5p to regulate YES1 expression in thyroid cancer.
The long noncoding RNA H19 is overexpressed in many cancers and acts as an oncogene. Here, we investigated the role of H19 in… (More)
Is this relevant?
2015
2015
Use of mechanistic models to integrate and analyze multiple proteomic datasets.
Proteins in cell signaling networks tend to interact promiscuously through low-affinity interactions. Consequently, evaluating… (More)
Is this relevant?
2014
2014
YAP1 (Yes-associated Protein 1)
YAP1 (Yes-associated protein; Hugo Nomenclature HGNC:16262), also known as YAP65, is the major downstream mediator of the… (More)
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2012
Highly Cited
2012
β-Catenin-Driven Cancers Require a YAP1 Transcriptional Complex for Survival and Tumorigenesis
Wnt/β-catenin signaling plays a key role in the pathogenesis of colon and other cancers; emerging evidence indicates that… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2011
2011
Gene expression signatures associated with the in vitro resistance to two tyrosine kinase inhibitors, nilotinib and imatinib
The use of selective inhibitors targeting Bcr-Abl kinase is now established as a standard protocol in the treatment of chronic… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2010
2010
Identification of the YES1 Kinase as a Therapeutic Target in Basal-Like Breast Cancers.
Normal cellular behavior can be described as a complex, regulated network of interaction between genes and proteins. Targeted… (More)
Is this relevant?
2003
2003
Genomic alterations in blastic natural killer/extranodal natural killer-like T cell lymphoma with cutaneous involvement.
Natural killer and natural killer-like T cell lymphomas represent a rare type of non-Hodgkin's lymphoma originally described to… (More)
Is this relevant?
2001
2001
Pharmacogenomic dissection of resistance to thymidylate synthase inhibitors.
Chemoresistance is a major obstacle for successful cancer treatment. Gene amplification and altered expression are the main… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1998
1998
Mapping of tyrosine kinase gene family members in a Xiphophorus melanoma model.
Xiphophorus fish have been the subject of intensive genetic research for more than 60 yr, primarily because of the availability… (More)
Is this relevant?
1993
1993
Chromosomal reassignment: YACs containing both YES1 and thymidylate synthase map to the short arm of chromosome 18.
The YES1 proto-oncogene was mapped previously to human chromosome band 18q21.3 by using isotopic in situ hybridization. Using… (More)
Is this relevant?